Treatment of measles virus-infected cells with 1 mM N,a-tosyl-L-phenylalanine chloromethyl ketone (TPCK) was observed to change the polyacrylamide gel migration of viral polypeptides P and M. Untreated cells contained P as a mixture of P1 (70,000 daltons) and P2 (65,000 daltons) and M as a 38,000-dalton band M1 and a slightly smaller band, M2. TPCK treatment resulted in conversion of P largely to the 65,000-dalton band and of M to M1 and a slightly slower-migrating band. This effect could also be demonstrated by treating homogenates of infected cells with TPCK, and the evidence suggests that the compound reacts directly with the viral P and M polypeptides and thereby changes their gel migration. TPCK also inhibited measles virus-associated protein kinase, and treatment of virion preparations with the compound resulted in a loss of infectivity; however, it was not possible to directly correlate the inhibitory effect on these two biological functions with the change seen in polypeptides P and M.
Treatment of measles virus-infected cells with 1 mM N,a-tosyl-L-phenylalanine chloromethyl ketone (TPCK) was observed to change the polyacrylamide gel migration of viral polypeptides P and M. Untreated cells contained P as a mixture of P1 (70,000 daltons) and P2 (65,000 daltons) and M as a 38,000-dalton band M1 and a slightly smaller band, M2. TPCK treatment resulted in conversion of P largely to the 65,000-dalton band and of M to M1 and a slightly slower-migrating band. This effect could also be demonstrated by treating homogenates of infected cells with TPCK, and the evidence suggests that the compound reacts directly with the viral P and M polypeptides and thereby changes their gel migration. TPCK also inhibited measles virus-associated protein kinase, and treatment of virion preparations with the compound resulted in a loss of infectivity; however, it was not possible to directly correlate the inhibitory effect on these two biological functions with the change seen in polypeptides P and M.
Measles virus is a member of the morbillivirus subgroup of the paramyxoviruses. As such, it is composed of an outer envelope and an inner helical nucleocapsid core consisting of the viral genomic RNA coated by the repeating structural subunit polypeptide, NP (molecular weight, 60,000) and of fewer copies of polypeptides L (molecular weight, greater than 150,000), and P (molecular weight, 70,000) (1) . It is to the latter two polypeptides, L and P, that various enzymatic properties of viral cores related to synthesis and processing of RNA have been ascribed (1) . The closely related vesicular stomatitis virus (VSV) contains a polypeptide termed NS, which, like the paramyxovirus P protein, is nucleocapsid associated and phosphorylated and has been thought to play a role in viral RNA synthesis (2, 4, 6) . In the case of VSV, a variety of species of NS have been found, and the evidence suggests that these species may represent a mechanism of regulation of the role of NS during viral replication. Kingsford and Emerson found two varieties of NS in virions which differed by degree of phosphorylation, and in vitro RNA synthesis could be reconstituted only by the more highly phosphorylated of the two (6) . Lesnaw et al. found that in the El ts mutant of VSV there is a mutation of NS which effects its structural conformation as reflected by migration on polyacrylamide gels and also results in a block of viral RNA replication but not in primary transcription (9) . The measles virus P protein also occurs in the infected cell as two species, P1 and P2, which migrate at 70,000 and 65,000 daltons, respectively, on polyacrylamide gels in the presence of a reducing agent (3). The measles virus M (matrix) protein occurs as two forms which are also separable on gel electrophoresis as M1 and M2, respectively (3). The M protein is an envelope protein, but changes in M phosphorylation have been suggested to exert control of paramyxovirus RNA synthesis (T. J. Miller and H. 0. Stone, Abstr. Annu. Meet. Am. Soc. Microbiol. 1978 , S136, p. 235).
The finding of two species of measles virus M and P polypeptides may reflect conformational changes or other protein modifications which are used as control mechanisms to regulate the physiological function of the proteins. This report describes the property of the chloromethyl ketone compounds N,a-p-tosyl-L-lysine chloromethyl ketone (TLCK) and N,a-tosyl-L-phenylalanine chloromethyl ketone (TPCK) to change the gel migration of the P and M polypeptides in such a way that P is changed to P2 and M to M1 and a slightly larger species. Experiments were carried out to elucidate the mechanism by which TPCK exerts this effect, and the evidence presented indicates a direct reaction of the compound with the P and M polypeptides. Since TPCK and TLCK were originally synthesized as affinity labels which bind to and irreversibly inhibit the enzymes chymotrypsin and trypsin (12) , it is possible that the interaction of the compounds with measles polypeptides P and M is a clue to enzymatic activity carried by these polypeptides. Indeed, it has been previously reported that TPCK and TLCK inhibit the pro-tein kinase of rabbit muscle (7) and of VSV (15 (3) were used (see Fig. 2 and 3) .
TPCK treatment. TPCK and TLCK were made as 100 mM stock solutions in dimethyl sulfoxide. Infected cell monolayers were incubated with radioisotope as described above, and TPCK solution was added for the last 30 min of the labeling period. Homogenates of infected, radioisotope-labeled HeLa cells were made by scraping cells in 0.5 ml of 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2'-ethanesulfonic acid) buffer (pH 7.0) per dish, followed by passing through a no. 21 needle with a syringe 10 times to disrupt cells. To 25 p.l of homogenate was added 2.5 ,u1 of TPCK in dimethyl sulfoxide, and the mixture was incubated for 30 min at 20°C. Electrophoresis sample buffer was added, and the entire sample was analyzed by polyacrylamide gel electrophoresis (3).
Infectivity studies. To 1-ml samples of virus stock were added 10 p.l of dimethyl sulfoxide, 100 mM TPCK, or 100 mM 2-chloroacetamide in dimethyl sulfoxide. After 30 min at room temperature, the samples were serially diluted and plaque assayed as previously described (3).
Virus-associated protein kinase. Measles virus was grown and purified as previously described (10) . As a comparison, VSV (San Juan strain, from M. A. Markwell, University of California, Los Angeles) was also grown in Vero cells and purified in the same way. Protein kinase assay was done as described by Witt and Summers (15) . Briefly, incubation mixtures contained 10 p.g of viral protein, 10 p.M ATP with 100,000 cpm of [y-32P]ATP, 0.1% Nonidet P-40, 0.1 M Tris (pH 8.6), 10 mM MgC92, and 10 mM dithioethreitol in a total volume of 100 p.l. Standard incubation was for 5 min at 28°C, and the reaction was stopped by adding carrier bovine serum albumin (50 ,ug) and 2 volumes of 10% trichloroacetic acid. The resulting precipitate was centrifuged, redissolved in 100 ,ul of 0.1 N NaOH, and reprecipitated with 0.5 ml of 10% trichloracetic acid. A total of three such precipitations were needed before transfer of samples to paper filters and washing to reduce the background of nonincubated controls to a value of less than 5% of that for an incubated sample.
Incorporation of 32p was assayed by liquid scintillation counting.
TPCK inhibition of protein kinase. Virus (10 p.g of viral protein) was preincubated in a total volume of 20 p.l containing 0.1 M HEPES buffer (pH 7.5), 0.1% Nonidet P-40, and inhibitor (either TPCK, TLCK, 2-chloroacetimide, or iodoacetamide at 1.0 and 10.0 mM) for 30 min at 28°C. The reaction was begun by adding 180 p.l of cocktail containing assay components, followed by a 5-min, 28°C incubation and processing as described above.
Polyacrylamide gel electrophoresis. Analysis was done on 10% polyacrylamide slab gels, followed by fluorography (for 3H) or direct radioautography (for 32P and 35S), and peptide mapping was done by limited digestion of excised polypeptide bands and electrophoresis of digest fragment patterns on a 17% gel as previously described (3), using 0.1 p.g of S. aureus protease V8 per cell.
RESULTS AND DISCUSSION Figure 1A shows viral polypeptides in a control and a TPCK-treated measles-infected HeLa cell culture. In the control cells, P was found mostly in the P1 form, and M was evenly distributed between its Ml and M2 forms. In contrast, the TPCK-treated culture showed an almost complete change of P into the P2 form and of M into the M1 form. In addition, a faint band could be seen migrating just above Ml in the TPCKtreated cells, which was found to represent another form of M induced by TPCK (see Fig.  2 ). To determine whether the P2 polypeptide induced by TPCK is incorporated into viral structures, infected cells were radiolabeled and then treated with 0.5 mM TPCK for 30 min before disruption of the cells and isolation of nucleocapsids (11) . Fig. 1B shows results of this experiment. Both control and TPCK-treated cells yielded nucleocapsids of similar buoyant density (1.29406 g/ml at 25°C in CsCI), but the treated nucleocapsids contained 72% of P as P2 compared with the control structures which contained 74% as P1. This data indicates that the P2 polypeptide found in the TPCK-treated cells is incorporated into viral nucleocapsid structures. Plaque titers of supernatants from the TPCKtreated cells showed a 100-fold reduction compared with the control, but gel analysis (data not shown) of the virions showed no change in polypeptides P and M. The effect of TPCK on virion infectivity is discussed below.
Peptide mapping experiments. The presence of a 65,000-dalton polypeptide and a change of (13) . A previous publication from this laboratory showed similar peptide maps for the 70,000-dalton P1, the 65,000-dalton P2 from untreated cells, and the 65,000-dalton P2 found in TPCK-treated cells, proving that these are three forms of the P polypeptide; similarly, peptide maps of M1 and M2 were presented showing that these are two forms of M resolved on the gel (3) . Figure 2 shows peptide maps of the band (designated 1) which migrated just above M1 in TPCK-treated (7) and for VSV in that a concentration of 10 mM TPCK is required for significant inhibition (15) . Since TPCK concentrations as low as 0.1 mM can change P to P2 in the infected cell, there is a lack of correlation of the two properties of TPCK. This lack of correlation is taken as evidence that significant inhibition of protein kinase is not required for the change induced by the compound in the P protein.
Inhibitors of protein synthesis and other protease inhibitors. Since both TLCK and TPCK are known to inhibit protein synthesis (13) , it was possible that this property of the compounds was responsible for effecting changes in polypeptides P and M. Experiments were therefore done with puromycin and cycloheximide at concentrations of 0.1 to 1.0 mM, which inhibited protein synthesis to an extent similar or greater than that found with TPCK. These experiments showed no change in polypeptides P and M caused by these agents (data not shown). Soybean trypsin inhibitor is another protease inhibitor but is chemically unrelated to the chloromethyl ketones and was similarly shown to have no effect on polypeptides P and M at inhibitor concentrations of up to 20 mg/ml. Similarly, phenylmethylsulfonyl fluoride, a protease inhibitor commonly incorporated into radioimmune precipitation buffer, was tested and had no effect on polypeptides P and M at concentrations of up to 1 mM. These experiments indicated that the properties of protease inhibition and protein synthesis inhibition were unlikely to explain the effect of the chloromethyl ketones on measles virus polypeptides P and M; instead, they suggested a direct interaction of the compounds with the viral polypeptides.
Direct reaction of TPCK with P and M proteins in homogenates of infected cells. As mentioned above, incubation of virion or nucleocapsid preparations with TPCK has not been successful in reproducing the effect on polypeptides P and M seen in infected cells. However, in vitro treatment of homogenates of infected cells with TPCK has been done, and the results are similar to those obtained by in vivo treatment of infected cell monolayers with the agent. Figure 3 shows in vitro modification of P and M polypeptides in infected cell homogenates and the results of some experiments designed to characterize the reaction. In vitro treatment of an infected cell homogenate with 1 mM TPCK (Fig. 3, lane  4) gives the same effect on polypeptides P and M as that seen with direct in vivo treatment of the infected cell monolayer (lane 2); heating the extract to 100°C for 1 min before adding TPCK does not inhibit the effect (lane 5), but heating to 100°C does not itself alter the P and M polypep- In other experiments, both 1% sodium dodecyl sulfate and 2% Nonidet P-40 were shown to abolish the in vitro effect, suggesting that integrity of a membrane structure may be required for the modification of P and M. Resistance to heating indicates that the changes in mobility induced in P and M do not represent results of an enzymatic process. Proteins previously shown to interact with TPCK and TLCK are the proteolytic enzymes chymotrypsin, trypsin, and papain (12, 14) and the protein kinase of rabbit muscle (7) , and in these examples there is a concomitant loss of enzymatic function. The chloromethyl ketones also inhibit the virionassociated protein kinase of VSV and measles virus (15; Table 1), and it is possible that this inhibition also involves covalent binding of the compound to the enzyme. The above data suggest that the measles virus P and M proteins are likely to be the specific polypeptides to which these inhibitors bind. However, as noted above, there is not a one-to-one correspondence between the effect of TPCK on viral polypeptides P and M and its inhibitory effect on the one enzymatic activity assayed in this work, the protein kinase, since the latter effect requires higher concentrations of TPCK and virion preparations inhibited by TPCK do not contain electrophoretically altered P and M polypeptides.
TPCK effect on viral infectivity. Measles virus stock (1 ml) was treated with 10 ,ul of 100 mM stock solutions of various inhibitors. The control was treated with dimethyl sulfoxide alone. After 30 min of incubation at 25°C, serial dilutions were prepared, and the plaque assay was carried out. The infectivity was 4 x 107, 5 x 105, and 4
x 107 PFU/ml for the control, the stock treated with 1 mM TPCK for 30 min, and the stock treated with 1 mM chloroacetamide for 30 min, respectively. Thus, when virus stock was incubated for 30 min with 1 mM TPCK, an approximately 100-fold loss in infectivity was noted as assayed by plaque titer. Chloroacetamide, a compound which contains the chloromethyl ketone group of TPCK and TLCK and which would be expected to be even more reactive with SH groups (7), had no such effect on infectivity or on assays of protein kinase. These data indicate that some virion function, presumably enzymatic, is sensitive to 1 mM TPCK and that this function is essential for viral infectivity. As noted above, the viral protein kinase is not likely to be the enzymatic property in question, as it is not appreciably (less than 20%) inhibited by 1 mM TPCK. The data do not exclude the possibility that there is more than one kinase in the measles virus preparation as assayed and that one specific kinase representing less than 20% of the total activity is sensitive to 1 mM TPCK and is crucial for viral infectivity. Another virion-associated activity is the RNA polymerase. Witt and Summers reported that for VSV this activity was also sensitive to TLCK and TPCK but found that concentrations of 10 mM were required, just as for the VSV protein kinase (15) . More detailed studies of inhibition of in vitro RNA synthesis might show an effect of TPCK at lower concentrations on the control of RNA synthesis, for example, in production of full-length positive strands versus the production and processing of messages. Lastly, the property discussed in this paper of the interac-tion of the compounds with the viral P and M proteins does occur at concentrations of 1 mM and lower. However, TPCK treatment of isolated virion preparations, in contrast to infected cell homogenates, did not result in the characteristic change in P and M seen on gel analysis. The present data do not prove direct covalent binding of TPCK to polypeptides P and M in virions but leave the possibility that this may occur without the changes in gel mobility seen in experiments with homogenates.
Further studies with radiolabeled TPCK and TLCK will be needed to determine whether the compounds are covalently attaching to viral proteins under conditions used in studies of inhibition of viral infectivity and enzymatic activity.
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